论文信息 - A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma - 字舞流文

A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma

J. Sosman | J. Kirkwood | P. Hersey | R. Gonzalez | S. O’Day | W. Sharfman | A. Bedikian | R. Weber | J. Richards | T. Logan | L. Hammershaimb | Manuela Buzoianu | S. O'Day